The Coffee That Pays You Back!

Fine out more information about Ganoderma in our Coffee's and Tea's at www.americashealthiercoffee.com
Showing posts with label Kidney. Show all posts
Showing posts with label Kidney. Show all posts

Tuesday, July 17, 2012

Obese Patients Face Increased Risk Of Kidney Damage After Heart Surgery

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our cardiovascular / cardiology section for the latest news on this subject. Study co-authors include Mias Pretorius, MD, Jonathan Schildcrout, PhD, Nathaniel Mercaldo, John Byrne, MD, T. Alp Ikizler, MD, Nancy J. Brown, MD (Vanderbilt University School of Medicine).

Disclosures: The authors reported no financial disclosures.

The article, entitled "Obesity and Oxidative Stress Predict Acute Kidney Injury Following Cardiac Surgery," will appear online at http://jasn.asnjournals.org/ on May 24, 2012, doi: 10.1681/ASN.2011090940.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

American Society of Nephrology

Please use one of the following formats to cite this article in your essay, paper or report:

MLA

American Society of Nephrology. "Obese Patients Face Increased Risk Of Kidney Damage After Heart Surgery." Medical News Today. MediLexicon, Intl., 28 May. 2012. Web.
7 Jun. 2012. APA

Please note: If no author information is provided, the source is cited instead.


View the original article here

Wednesday, July 11, 2012

Potential For Human Intravenous Kidney Cell Transplants

Main Category: Urology / Nephrology
Also Included In: Transplants / Organ Donations;  Diabetes
Article Date: 04 Jun 2012 - 0:00 PDT Current ratings for:
'Potential For Human Intravenous Kidney Cell Transplants'
5 starsnot yet rated
Indiana University School of Medicine scientists have successfully transplanted primary kidney cells intravenously to treat renal failure in rats, pointing the way to a possible future alternative to kidney transplants and expensive dialysis treatments in humans.

The researchers, Katherine J. Kelly, M.D., associate professor of medicine, and Jesus Dominguez, M.D., professor of medicine, genetically modified the cells in the laboratory to produce a protein - called SAA - that plays an important role in renal cell growth, embryonic kidney development and kidney regeneration after an injury. Modified cells found their way to the appropriate locations of the damaged kidneys, resulting in regeneration of tissue and improved function in the kidney.

The researchers' work has been accepted for publication in the American Journal of Physiology - Renal Physiology, now online.

The authors point out there is a significant and expanding need for better kidney treatments because growing numbers of people are facing progressive kidney failure due to rising incidence of diabetes, hypertension and the aging of the population.

According to the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health, more than 20 million Americans have chronic kidney disease, and more than half a million people are being treated for end stage renal disease. For those patients the options are limited to dialysis or kidney transplants. Nearly 99,000 people are now on the waiting list for a kidney transplant, according to the Organ Procurement and Transplantation Network, and more than 12 people die each day while on a kidney transplant waiting list.

"Obviously there is a need for, and an opportunity for, regenerative medicine in kidney failure as well as other organs," said Dr. Dominguez. There have been efforts to use stem cells to regenerate kidney tissue, but the benefits have not been long lasting, he noted.

In the IU researchers' experiments, however, some of the reprogrammed adult kidney donor cells made their way back to the damaged rat kidneys and engrafted themselves into key locations for renal function, resulting in improved kidney function and limiting physical damage. In some cases the modified cells came from other donor rats. In other experiments, one of the rats damaged kidneys was removed and the treated cells were grown in the laboratory and then returned to the same rat.

"Ultimately, you can imagine taking a part of someone's kidney, expanding those cells with appropriate growth factors in a tissue culture dish, and then giving the cells back," said Dr. Kelly.

The researchers cautioned, however, that much work remains to be done before tests could begin in humans.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our urology / nephrology section for the latest news on this subject. The research was supported in part with funds from the National Institutes of Health to Dr. Kelly (Grant no. 5R01DK082739) and the Veterans Administration Merit Review program to Dr. Dominguez.
Indiana University School of Medicine Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Indiana University School of Medicine. "Potential For Human Intravenous Kidney Cell Transplants." Medical News Today. MediLexicon, Intl., 4 Jun. 2012. Web.
7 Jun. 2012. APA

Please note: If no author information is provided, the source is cited instead.


'Potential For Human Intravenous Kidney Cell Transplants'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here

Tuesday, July 10, 2012

Kidney Failure In Type 2 Diabetes May Not Be Reduced By Aggressive Glucose Control

Main Category: Diabetes
Also Included In: Urology / Nephrology
Article Date: 29 May 2012 - 1:00 PDT Current ratings for:
'Kidney Failure In Type 2 Diabetes May Not Be Reduced By Aggressive Glucose Control'
3 stars4 stars
Yale School of Medicine researchers have found that intensively controlling glucose (glycemic) levels in type-2 diabetes patients may not reduce the risk of kidney failure. The study, which is a review of data from seven clinical trials, is published in the May 28 issue of Archives of Internal Medicine.

To test the hypothesis that aggressive glycemic control can prevent renal disease in patients with type 2 diabetes mellitus, first author Steven G. Coca of Yale and colleagues searched available medical literature and evaluated seven randomized trials involving 28,065 adult patients who were monitored for two to 15 years.

The team found that compared with those who had usual treatment, intensively controlling glucose with higher doses of medication did not definitively reduce the risk of impaired kidney function, the need for dialysis, or death from kidney disease.

Coca said many researchers have presumed that such intensive treatment would benefit patients by protecting the kidneys, but these results question whether patients truly are better off with this approach.

"After pooling the results from the follow-up data in the seven studies examined, our analysis shows that intensive glycemic control may improve some things about the kidney that we measure, but did not affect patients' outcomes," said Coca, assistant professor in the section of nephrology in the Department of Internal Medicine at Yale.

Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our diabetes section for the latest news on this subject. Other authors on the study include Faramarz Ismail-Beigi, Nowreen Haq, Harlan M. Krumholz, and Chirag R. Parikh.
The study was funded in part by the National Heart, Lung, and Blood Institute Center for Cardiovascular Outcomes Research at Yale University. Krumholz is also the recipient of a research grant from Medtronic, Inc. through Yale University.
Citation: Arch Intern Med. Vol. 172, No. 10 (May 28, 2012)
Yale University Please use one of the following formats to cite this article in your essay, paper or report:

MLA

Yale University. "Kidney Failure In Type 2 Diabetes May Not Be Reduced By Aggressive Glucose Control." Medical News Today. MediLexicon, Intl., 29 May. 2012. Web.
7 Jun. 2012. APA

Please note: If no author information is provided, the source is cited instead.



'Kidney Failure In Type 2 Diabetes May Not Be Reduced By Aggressive Glucose Control'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



View the original article here